Search Results - "Bogomiakova, M. E."

Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing by Bogomiakova, M.E., Sekretova, E.K., Eremeev, A.V., Shuvalova, L.D., Bobrovsky, P.A., Zerkalenkova, E.A., Lebedeva, O.S., Lagarkova, M.A.

“…The mismatch of HLA haplotypes between donor and recipient adversely affects the outcome of tissue transplantation. TheB2Mgene knockout (B2M-KO) disrupts the…”
Get full text

At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines? by Bogomiakova, M. E., Eremeev, A. V., Lagarkova, M. A.

“…Human pluripotent stem cells, which include embryonic stem cells and induced pluripotent cells (iPSCs), are capable of unlimited division and differentiation…”
Get full text

“Necessity Is the Mother of Invention” or Inexpensive, Reliable, and Reproducible Protocol for Generating Organoids by Eremeev, A. V., Volovikov, E. A., Shuvalova, L. D., Davidenko, A. V., Khomyakova, E. A., Bogomiakova, M. E., Lebedeva, O. S., Zubkova, O. A., Lagarkova, M. A.

“…Organoids are three-dimensional (3D) cell cultures that replicate some of the key features of morphology, spatial architecture, and functions of a particular…”
Get full text